Timothy J Craig

The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update

R. Lockey, R. Pawankar, W. Lumry, 2018, Allergy.

Efficacy and safety of ecallantide in treatment of recurrent attacks of hereditary angioedema: open-label continuation study.

J. Bernstein, W. Lumry, T. Craig, 2013, Allergy and asthma proceedings.

Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks.

J. Biedenkapp, J. Bernstein, W. Lumry, 2015, The journal of allergy and clinical immunology. In practice.

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema

A. Hamed, M. Cicardi, K. Binkley, 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: a randomized, double-blind, placebo-controlled phase 3 trial.

William H. Yang, J. Bernstein, H. Iocca, 2020, The Journal of allergy and clinical immunology.

Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate

J. Bernstein, T. Craig, M. Cicardi, 2015, Allergy.

Patient outcomes associated with subcutaneous C1INH prophylaxis for hereditary angioedema: a retrospective analysis

W. Lumry, R. Tachdjian, M. Riedl, 2023, Allergy, Asthma & Clinical Immunology.

Current Status of Implementation of Self-Administration Training in Various Regions of Europe, Canada and the USA in the Management of Hereditary Angioedema

P. Keith, T. Craig, S. Neri, 2013, International Archives of Allergy and Immunology.